Clinical Trial Update: A Proof of Principle Study of Aminolevulinic Acid (ALA) - Induced Fluorescence Detection in Resectable Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

A Phase 1 proof-of-principle trial investigating aminolevulinic acid–induced fluorescence for detecting resectable non-small cell lung cancer has been withdrawn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Aminolevulinic acid (5-aminolevulinic acid)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Lung Cancer in Normal and Malignant Tumors | Phase 1 | Status: WITHDRAWN